Atara Biotherap (ATRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 200,598 | 74,511 | 60,892 | 79,417 | 48,162 |
| Marketable Securities | 300,255 | 184,792 | 248,933 | 86,873 | 207,714 |
| Receivables | 1,250 | N/A | N/A | N/A | N/A |
| TOTAL | $523,273 | $272,992 | $321,489 | $172,190 | $260,553 |
| Non-Current Assets | |||||
| PPE Net | 50,517 | 54,176 | 68,576 | 44,129 | 3,259 |
| Other Non-Current Assets | 14,330 | 15,774 | 1,774 | 1,460 | 102 |
| TOTAL | $64,847 | $69,950 | $70,350 | $45,589 | $3,361 |
| Total Assets | $588,120 | $342,942 | $391,839 | $217,779 | $263,914 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,118 | 7,963 | 3,719 | 14,711 | 2,778 |
| Accrued Expenses | 20,458 | 14,706 | 10,636 | 5,664 | 3,745 |
| Other current liabilities | 6,057 | 5,733 | 6,414 | 3,265 | N/A |
| TOTAL | $82,901 | $36,743 | $39,979 | $27,646 | $9,675 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 33,455 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 15,085 | 15,418 | 13,003 | 12,269 | 503 |
| TOTAL | $42,880 | $15,418 | $13,003 | $12,269 | $503 |
| Total Liabilities | $125,781 | $52,161 | $52,982 | $39,915 | $10,178 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,345 | 2,343 | 1,846 | 1,553 | 1,164 |
| Common Shares | 8 | 6 | 5 | 3 | 3 |
| Retained earnings | -1,124,581 | -817,961 | -527,349 | -296,650 | -177,159 |
| Other shareholders' equity | 296 | 220 | -340 | -151 | -183 |
| TOTAL | $462,339 | $290,781 | $338,857 | $177,864 | $253,736 |
| Total Liabilities And Equity | $588,120 | $342,942 | $391,839 | $217,779 | $263,914 |